These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 10506753)

  • 1. Simian virus 40 (SV40)-like DNA sequences not detectable in finnish mesothelioma patients not exposed to SV40-contaminated polio vaccines.
    Hirvonen A; Mattson K; Karjalainen A; Ollikainen T; Tammilehto L; Hovi T; Vainio H; Pass HI; Di Resta I; Carbone M; Linnainmaa K
    Mol Carcinog; 1999 Oct; 26(2):93-9. PubMed ID: 10506753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SV40-like DNA sequences in pleural mesothelioma, bronchopulmonary carcinoma, and non-malignant pulmonary diseases.
    Galateau-Salle F; Bidet P; Iwatsubo Y; Gennetay E; Renier A; Letourneux M; Pairon JC; Moritz S; Brochard P; Jaurand MC; Freymuth F
    J Pathol; 1998 Mar; 184(3):252-7. PubMed ID: 9614376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A multi-institutional study confirms the presence and expression of simian virus 40 in human malignant mesotheliomas.
    Testa JR; Carbone M; Hirvonen A; Khalili K; Krynska B; Linnainmaa K; Pooley FD; Rizzo P; Rusch V; Xiao GH
    Cancer Res; 1998 Oct; 58(20):4505-9. PubMed ID: 9788590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of SV40-like DNA sequences in pleural mesothelioma, bronchopulmonary carcinoma and other pulmonary diseases.
    Galateau-Salle F; Bidet P; Iwatsubo Y; Gennetay E; Renier A; Letourneux M; Pairon JC; Moritz S; Brochard P; Jaurand MC; Freymuth F
    Dev Biol Stand; 1998; 94():147-52. PubMed ID: 9776236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SV40, genetic polymorphism and mesothelioma. pathological and epidemiological evidence.
    Magnani C
    Med Lav; 2005; 96(4):347-53. PubMed ID: 16457431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of SV40 DNA sequences in malignant mesothelioma specimens from the United States, but not from Turkey.
    De Rienzo A; Tor M; Sterman DH; Aksoy F; Albelda SM; Testa JR
    J Cell Biochem; 2002; 84(3):455-9. PubMed ID: 11813251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential exposure to SV40 in polio vaccines used in Sweden during 1957: no impact on cancer incidence rates 1960 to 1993.
    Olin P; Giesecke J
    Dev Biol Stand; 1998; 94():227-33. PubMed ID: 9776244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of polio-vaccine in pleural mesothelioma--an epidemiological observation.
    Sarić M; Curin K; Varnai VM
    Coll Antropol; 2008 Jun; 32(2):479-83. PubMed ID: 18756898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SV40 multiple tissue infection and asbestos exposure in a hyperendemic area for malignant mesothelioma.
    Comar M; Rizzardi C; de Zotti R; Melato M; Bovenzi M; Butel JS; Campello C
    Cancer Res; 2007 Sep; 67(18):8456-9. PubMed ID: 17875683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Presence of simian virus 40 (SV40) is not frequent in Swedish malignant mesotheliomas.
    Priftakis P; Bogdanovic G; Hjerpe A; Dalianis T
    Anticancer Res; 2002; 22(3):1357-60. PubMed ID: 12168811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of simian virus-40 as a biological prognostic factor in Egyptian patients with malignant pleural mesothelioma.
    Zekri AR; Bahnassy AA; Mohamed WS; Hassan N; Abdel-Rahman AR; El-Kassem FA; Gaafar R
    Pathol Int; 2007 Aug; 57(8):493-501. PubMed ID: 17610473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SV40 expression in human neoplastic and non-neoplastic tissues: perspectives on diagnosis, prognosis and therapy of human malignant mesothelioma.
    Procopio A; Marinacci R; Marinetti MR; Strizzi L; Paludi D; Iezzi T; Tassi G; Casalini A; Modesti A
    Dev Biol Stand; 1998; 94():361-7. PubMed ID: 9776257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for and implications of SV40-like sequences in human mesotheliomas.
    Pass HI; Kennedy RC; Carbone M
    Important Adv Oncol; 1996; ():89-108. PubMed ID: 8791130
    [No Abstract]   [Full Text] [Related]  

  • 14. Simian virus 40 and malignant mesothelioma (Review).
    Cerrano PG; Jasani B; Filiberti R; Neri M; Merlo F; De Flora S; Mutti L; Puntoni R
    Int J Oncol; 2003 Jan; 22(1):187-94. PubMed ID: 12469203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simian virus 40-like DNA sequences in human pleural mesothelioma.
    Carbone M; Pass HI; Rizzo P; Marinetti M; Di Muzio M; Mew DJ; Levine AS; Procopio A
    Oncogene; 1994 Jun; 9(6):1781-90. PubMed ID: 8183577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation of simian virus 40 large T antigen in 18 autopsied malignant mesothelioma patients in Japan.
    Jin M; Sawa H; Suzuki T; Shimizu K; Makino Y; Tanaka S; Nojima T; Fujioka Y; Asamoto M; Suko N; Fujita M; Nagashima K
    J Med Virol; 2004 Dec; 74(4):668-76. PubMed ID: 15484269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. No detection of SV40 DNA in mesothelioma tissues from a high incidence area in Sweden.
    Lundstig A; Dejmek A; Eklund C; Filinic I; Dillner J
    Anticancer Res; 2007; 27(6B):4159-61. PubMed ID: 18225586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New molecular and epidemiological issues in mesothelioma: role of SV40.
    Carbone M; Fisher S; Powers A; Pass HI; Rizzo P
    J Cell Physiol; 1999 Aug; 180(2):167-72. PubMed ID: 10395286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [SV40: a possible co-carcinogen of asbestos in the pathogenesis of mesothelioma?].
    Cristaudo A; Foddis R; Bigdeli L; Vivaldi A; Buselli R; Guglielmi G; Guidi M; Ottenga F
    Med Lav; 2002; 93(6):499-506. PubMed ID: 12596420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular characterization of SV40 DNA in multiple samples from a human mesothelioma.
    Arrington AS; Lednicky JA; Butel JS
    Anticancer Res; 2000; 20(2A):879-84. PubMed ID: 10810370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.